Difference between revisions of "Part:BBa K3419005"
Line 5: | Line 5: | ||
Our kill switch consists of a holin-antiholin toxin-antitoxin system. The holin protein creates holes in the bacterial cell membrane, which allows endolysin protein to pass through and degrade the cell wall, killing the cell. The antiholin protein binds to the holin protein, inactivating it. When both proteins are expressed, whether the cell dies depends on the relative concentrations of both the holin and antiholin components. [1]. | Our kill switch consists of a holin-antiholin toxin-antitoxin system. The holin protein creates holes in the bacterial cell membrane, which allows endolysin protein to pass through and degrade the cell wall, killing the cell. The antiholin protein binds to the holin protein, inactivating it. When both proteins are expressed, whether the cell dies depends on the relative concentrations of both the holin and antiholin components. [1]. | ||
+ | |||
[[File:KillSwitchDiagram.png|700px|center|thumb|Figure 1. The kill switch consists of three different proteins: holin, which creates holes in the cell membrane; endolysin, which then passes through these holes to degrade the peptidoglycan found in the cell wall; antiholin, which binds to holin to create an inactivated dimer, preventing holes from being formed in the first place [2].]] | [[File:KillSwitchDiagram.png|700px|center|thumb|Figure 1. The kill switch consists of three different proteins: holin, which creates holes in the cell membrane; endolysin, which then passes through these holes to degrade the peptidoglycan found in the cell wall; antiholin, which binds to holin to create an inactivated dimer, preventing holes from being formed in the first place [2].]] | ||
+ | |||
This BioBrick has been designed as a modification to a traditional holin/antiholin kill switch so that the expression of antiholin is controlled by a lactate-inducible promoter, as research shows that lactate concentrations are higher in tumor environments (10-30 mM) compared to healthy tissue (1.5-3 mM) [3]. The toxin, holin, is expressed under a constitutive promoter, as in a typical holin/antiholin kill switch. When in the presence of high lactate, enough antitoxin (antiholin) is produced under the lactate inducible promoter to significantly counteract holin. Otherwise, antiholin is not sufficiently produced, and the bacteria soon die. This allows the bacteria to localize and survive in high-lactate environments such as tumor cells, and die in other environments (i.e. healthy human tissue), as shown in Figure 2. | This BioBrick has been designed as a modification to a traditional holin/antiholin kill switch so that the expression of antiholin is controlled by a lactate-inducible promoter, as research shows that lactate concentrations are higher in tumor environments (10-30 mM) compared to healthy tissue (1.5-3 mM) [3]. The toxin, holin, is expressed under a constitutive promoter, as in a typical holin/antiholin kill switch. When in the presence of high lactate, enough antitoxin (antiholin) is produced under the lactate inducible promoter to significantly counteract holin. Otherwise, antiholin is not sufficiently produced, and the bacteria soon die. This allows the bacteria to localize and survive in high-lactate environments such as tumor cells, and die in other environments (i.e. healthy human tissue), as shown in Figure 2. | ||
+ | |||
[[File:KillSwitchMechanism.png|900px|center|thumb|Figure 2. Diagram depicting the mechanism for the overall kill switch to encourage cell survival in cancerous, or high lactate, environments, and induce cell lysis in healthy tissue.]] | [[File:KillSwitchMechanism.png|900px|center|thumb|Figure 2. Diagram depicting the mechanism for the overall kill switch to encourage cell survival in cancerous, or high lactate, environments, and induce cell lysis in healthy tissue.]] | ||
+ | |||
===Improvement=== | ===Improvement=== | ||
A degradation tag is attached to the holin protein, which marks it for disposal and reduces its half-life in the cell. This limits the activity of the holin toxin prevents its buildup over time, allowing the bacterial population to survive indefinitely as long as it is within a high-lactate tumor environment. | A degradation tag is attached to the holin protein, which marks it for disposal and reduces its half-life in the cell. This limits the activity of the holin toxin prevents its buildup over time, allowing the bacterial population to survive indefinitely as long as it is within a high-lactate tumor environment. | ||
+ | |||
[[File:degtag.png|800px|center|thumb|Figure 3. Comparison of the kill switch modeling with a degradation tag (top three plots) show a good distinction between cancerous and non-cancerous tissue. The kill switch without the degradation tag does not make this clear of a distinction (bottom).]] | [[File:degtag.png|800px|center|thumb|Figure 3. Comparison of the kill switch modeling with a degradation tag (top three plots) show a good distinction between cancerous and non-cancerous tissue. The kill switch without the degradation tag does not make this clear of a distinction (bottom).]] | ||
+ | |||
With our improved holin part (ie. with degradation tag), there is good distinction between physiologically normal levels of lactate, and cancerous levels of lactate. In other words, with the degradation tag, the bacteria will survive in a tumor environment, and die in healthy tissue. | With our improved holin part (ie. with degradation tag), there is good distinction between physiologically normal levels of lactate, and cancerous levels of lactate. In other words, with the degradation tag, the bacteria will survive in a tumor environment, and die in healthy tissue. | ||
Line 31: | Line 37: | ||
Anti-toxin diff eq: | Anti-toxin diff eq: | ||
[[File:Antitoxin.png|700px|center]] | [[File:Antitoxin.png|700px|center]] | ||
+ | |||
The second equation represents the rate at which holin is being produced. The terms respectively represent the expression from the constitutive promoter, removal due to degradation, removal due to binding to antiholin (to form the inactivated holin-antiholin dimer), and addition due to disassociation of the holin from the holin-antiholin dimer. | The second equation represents the rate at which holin is being produced. The terms respectively represent the expression from the constitutive promoter, removal due to degradation, removal due to binding to antiholin (to form the inactivated holin-antiholin dimer), and addition due to disassociation of the holin from the holin-antiholin dimer. | ||
Line 36: | Line 43: | ||
Toxin diff eq: | Toxin diff eq: | ||
[[File:Toxin.png|700px|center]] | [[File:Toxin.png|700px|center]] | ||
+ | |||
The third equation represents the rate at which the holin-antiholin dimer is formed. The terms respectively represent the reaction rate at which holin and antiholin bind, the rate at which the dimer disassociates, and the rate at which the dimer degrades. | The third equation represents the rate at which the holin-antiholin dimer is formed. The terms respectively represent the reaction rate at which holin and antiholin bind, the rate at which the dimer disassociates, and the rate at which the dimer degrades. | ||
Line 168: | Line 176: | ||
Figures 4-6 show the concentrations of holin, antiholin, and the inactivated holin-antiholin dimer at different levels of lactate. At a lethal concentration of 1.66 μM, holin kills the bacterial cell [1]. Whether holin reaches this level depends on the relative concentration of antiholin, whose expression is influenced by the lactate level of the surrounding environment. | Figures 4-6 show the concentrations of holin, antiholin, and the inactivated holin-antiholin dimer at different levels of lactate. At a lethal concentration of 1.66 μM, holin kills the bacterial cell [1]. Whether holin reaches this level depends on the relative concentration of antiholin, whose expression is influenced by the lactate level of the surrounding environment. | ||
+ | |||
[[File:KillSwitch1mM.png|500px|center|thumb|Figure 4. At 1mM, a very low level of lactate (L) that would be expected outside of the tumor environment, the steady-state concentration of holin is 5.47 μM. This indicates that under these conditions, the bacteria will not infiltrate healthy tissue.]] | [[File:KillSwitch1mM.png|500px|center|thumb|Figure 4. At 1mM, a very low level of lactate (L) that would be expected outside of the tumor environment, the steady-state concentration of holin is 5.47 μM. This indicates that under these conditions, the bacteria will not infiltrate healthy tissue.]] |
Revision as of 00:46, 19 October 2020
Contents
Holin/Anti-Holin Kill Switch with Degradation Tag and Lactate Inducible Promoter
Mechanism
Note: All work on this part was done virtually through literature research due to COVID-19 restrictions.
Our kill switch consists of a holin-antiholin toxin-antitoxin system. The holin protein creates holes in the bacterial cell membrane, which allows endolysin protein to pass through and degrade the cell wall, killing the cell. The antiholin protein binds to the holin protein, inactivating it. When both proteins are expressed, whether the cell dies depends on the relative concentrations of both the holin and antiholin components. [1].
This BioBrick has been designed as a modification to a traditional holin/antiholin kill switch so that the expression of antiholin is controlled by a lactate-inducible promoter, as research shows that lactate concentrations are higher in tumor environments (10-30 mM) compared to healthy tissue (1.5-3 mM) [3]. The toxin, holin, is expressed under a constitutive promoter, as in a typical holin/antiholin kill switch. When in the presence of high lactate, enough antitoxin (antiholin) is produced under the lactate inducible promoter to significantly counteract holin. Otherwise, antiholin is not sufficiently produced, and the bacteria soon die. This allows the bacteria to localize and survive in high-lactate environments such as tumor cells, and die in other environments (i.e. healthy human tissue), as shown in Figure 2.
Improvement
A degradation tag is attached to the holin protein, which marks it for disposal and reduces its half-life in the cell. This limits the activity of the holin toxin prevents its buildup over time, allowing the bacterial population to survive indefinitely as long as it is within a high-lactate tumor environment.
With our improved holin part (ie. with degradation tag), there is good distinction between physiologically normal levels of lactate, and cancerous levels of lactate. In other words, with the degradation tag, the bacteria will survive in a tumor environment, and die in healthy tissue.
However, without our improvement (ie. without degradation tag), as can be seen in the bottom panel of Figure 3, the holin concentration of all of them is between 0.65 uM and 0.75 uM for concentrations throughout 1 mM to 30 mM, both of which would allow survival. Since this range all allows for bacterial survival, this kill switch would not be specific to cancer tissue without the degradation tag.
Modeling
The following three differential equations were used to model our holin-antiholin kill switch. These equations were solved using Matlab’s built-in ordinary differential equation solver ode45.
The first equation represents the rate at which antiholin is being produced . The terms respectively represent expression from the lactate promoter, removal due to degradation, removal due to the binding to holin (to form the inactivated holin-antiholin dimer), and addition due to disassociation of the holin-antiholin dimer.
Anti-toxin diff eq:
The second equation represents the rate at which holin is being produced. The terms respectively represent the expression from the constitutive promoter, removal due to degradation, removal due to binding to antiholin (to form the inactivated holin-antiholin dimer), and addition due to disassociation of the holin from the holin-antiholin dimer.
Toxin diff eq:
The third equation represents the rate at which the holin-antiholin dimer is formed. The terms respectively represent the reaction rate at which holin and antiholin bind, the rate at which the dimer disassociates, and the rate at which the dimer degrades.
Toxin-antitoxin complex diff eq:
The MATLAB scripts corresponding to the mCardinal modeling can be downloaded here:
File:ModelingCodeCornelliGEM2020.zip
Table 1. Parameter Values for Kill Switch Modeling
Variable | Parameter | Value | Source |
---|---|---|---|
[Antitoxin] | Concentration of Antitoxin | -- | -- |
[Toxin] | Concentration of Toxin | -- | -- |
[Dimer] | Concentration of toxin-antitoxin dimer | -- | |
f | Fluorescent Scaling Factor | = const. exp / (basA + a) = (23.22 uM/min) / (7790 uM/min) = 2.98 *10^-3 | [4][5] |
basA | Basal exp of lactate promoter | 479.3 [uM/min] | [4] |
KdA | Dissociation constant for lactate promoter | 1075 [uM] | [4] |
n | Exponent | 1.326 | [4] |
a | Induced transcription scaling factor | 7311 [uM/min] | [4] |
dA | Rate const, degradation of antitoxin (degradation tag) | 0.13 [min^-1] | [6] |
dT | Rate const, degradation of toxin | 0.0348 [min^-1] | [1] |
[Lac] | Lactate concentration | 1 to 30 [mM] | [3] |
kf | Rate const, forward rxn:T + A ↔ TA | 1.2 * 10^-4 [uM^-1min^-1] | [1] |
kb | Rate const, reverse rxn:T + A ↔ TA | 0.3 * 10^-4 [min^-1] | [4] |
basT | Basal exp of weak constitutive promoter (assume infinite lactate) | 23.22 uM/min for strong promoter J23100, scale by relative strength of J23108 * (1303 / 2547)= 11.87 uM/min= 0.198 [uM/s] | [5][7] |
dD | Rate const, degradation of toxin-antitoxin dimer | 0.0348 [min^-1] | [1] |
Figures 4-6 show the concentrations of holin, antiholin, and the inactivated holin-antiholin dimer at different levels of lactate. At a lethal concentration of 1.66 μM, holin kills the bacterial cell [1]. Whether holin reaches this level depends on the relative concentration of antiholin, whose expression is influenced by the lactate level of the surrounding environment.
References:
[1] Kill Switch. (2013). Retrieved October 14, 2020, from http://2013.igem.org/KillSwitch
[2] Jie, W. (2014). BBa_K1378032. Retrieved October 13, 2020, from https://parts.igem.org/Part:BBa_K1378032
[3] Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019). Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches. Frontiers in Oncology, 9. doi:10.3389/fonc.2019.01143
[4] Fomitcheva, A. (2015). BBa_K1847009. Retrieved October 14, 2020, from https://parts.igem.org/Part:BBa_K1847009
[5] Yildirim, N., & Mackey, M. C. (2003). Feedback Regulation in the Lactose Operon: A Mathematical Modeling Study and Comparison with Experimental Data. Biophysical Journal, 84(5), 2841-2851. doi:10.1016/s0006-3495(03)70013-7
[6] Guan, R. (2013). BBa_K1051208. Retrieved October 14, 2020, from https://parts.igem.org/Part:BBa_K1051208
[7] Anderson, J. (2006). BBa_J23117. Retrieved October 14, 2020, from https://parts.igem.org/Part:BBa_J23117